AAAAAA

   
Results: 1-25 | 26-50 | 51-69
Results: 1-25/69

Authors: Hadano, S Hand, CK Osuga, H Yanagisawa, Y Otomo, A Devon, RS Miyamoto, N Showguchi-Miyata, J Okada, Y Singaraja, R Figlewicz, DA Kwiatkowski, T Hosler, BA Sagie, T Skaug, J Nasir, J Brown, RH Scherer, SW Rouleau, GA Hayden, MR Ikeda, JE
Citation: S. Hadano et al., A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 (vol 29, pg 166, 2001), NAT GENET, 29(3), 2001, pp. 352-352

Authors: Hadano, S Hand, CK Osuga, H Yanagisawa, Y Otomo, A Devon, RS Miyamoto, N Showguchi-Miyata, J Okada, Y Singaraja, R Figlewicz, DA Kwiatkowski, T Hosler, BA Sagie, T Skaug, J Nasir, J Brown, RH Scherer, SW Rouleau, GA Hayden, MR Ikeda, JE
Citation: S. Hadano et al., A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2, NAT GENET, 29(2), 2001, pp. 166-173

Authors: Zeron, MM Chen, NS Moshaver, A Lee, ATC Wellington, CL Hayden, MR Raymond, LA
Citation: Mm. Zeron et al., Mutant huntingtin enhances excitotoxic cell death, MOL CELL NE, 17(1), 2001, pp. 41-53

Authors: Peel, AL Rao, RV Cottrell, BA Hayden, MR Ellerby, LM Bredesen, DE
Citation: Al. Peel et al., Double-stranded RNA-dependent protein kinase, PKR, binds preferentially toHuntington's disease (HD) transcripts and is activated in HD tissue, HUM MOL GEN, 10(15), 2001, pp. 1531-1538

Authors: Emsley, RA Niehaus, DJH Mbanga, NI Oosthuizen, PP Stein, DJ Maritz, JS Pimstone, SN Hayden, MR Laurent, C Deleuze, JF Mallet, J
Citation: Ra. Emsley et al., The factor structure for positive and negative symptoms in South African Xhosa patients with schizophrenia, SCHIZOPHR R, 47(2-3), 2001, pp. 149-157

Authors: Hadano, S Yanagisawa, Y Skaug, J Fichter, K Nasir, J Martindale, D Koop, BF Scherer, SW Nicholson, DW Rouleau, GA Ikeda, JE Hayden, MR
Citation: S. Hadano et al., Cloning and characterization of three novel genes, ALS2CR1, ALS2CR2, and ALS2CR3, in the juvenile amyotrophic lateral sclerosis (ALS2) critical region at chromosome 2q33-q34: Candidate genes for ALS2, GENOMICS, 71(2), 2001, pp. 200-213

Authors: Squitieri, F Cannella, M Giallonardo, P Maglione, V Mariotti, C Hayden, MR
Citation: F. Squitieri et al., Onset and pre-onset studies to define the Huntington's disease natural history, BRAIN RES B, 56(3-4), 2001, pp. 233-238

Authors: Rosenblatt, A Brinkman, RR Liang, KY Almqvist, EW Margolis, RL Huang, CY Sherr, M Franz, ML Abbott, MH Hayden, MR Ross, CA
Citation: A. Rosenblatt et al., Familial influence on age of onset among siblings with Huntington disease, AM J MED G, 105(5), 2001, pp. 399-403

Authors: Zuccato, C Ciammola, A Rigamonti, D Leavitt, BR Goffredo, D Conti, L MacDonald, ME Friedlander, RM Silani, V Hayden, MR Timmusk, T Sipione, S Cattaneo, E
Citation: C. Zuccato et al., Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease, SCIENCE, 293(5529), 2001, pp. 493-498

Authors: Paulsen, JS Zhao, H Stout, JC Brinkman, RR Guttman, M Ross, CA Como, P Manning, C Hayden, MR Shoulson, I
Citation: Js. Paulsen et al., Clinical markers of early disease in persons near onset of Huntington's disease, NEUROLOGY, 57(4), 2001, pp. 658-662

Authors: Clarke, G Collins, RA Leavitt, BR Andrews, DF Hayden, MR Lumsden, CJ McInnes, RR
Citation: G. Clarke et al., A one-hit model of cell death in inherited neuronal degenerations (vol 406, pg 195, 2000), NATURE, 409(6819), 2001, pp. 542

Authors: Holbert, S Denghien, I Kiechle, T Rosenblatt, A Wellington, C Hayden, MR Margolis, RL Ross, CA Dausset, J Ferrante, RJ Neri, C
Citation: S. Holbert et al., The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: Neuropathologic and genetic evidence for a role in Huntington's diseasepathogenesis, P NAS US, 98(4), 2001, pp. 1811-1816

Authors: Attie, AD Kastelein, JP Hayden, MR
Citation: Ad. Attie et al., Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis, J LIPID RES, 42(11), 2001, pp. 1717-1726

Authors: Metzler, M Legendre-Guillemin, V Gan, L Chopra, V Kwok, A McPherson, PS Hayden, MR
Citation: M. Metzler et al., HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2, J BIOL CHEM, 276(42), 2001, pp. 39271-39276

Authors: Singaraja, RR Bocher, V James, ER Clee, SM Zhang, LH Leavitt, BR Tan, B Brooks-Wilson, A Kwok, A Bissada, N Yang, YZ Liu, GQ Tafuri, SR Fievet, C Wellington, CL Staels, B Hayden, MR
Citation: Rr. Singaraja et al., Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and apoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1, J BIOL CHEM, 276(36), 2001, pp. 33969-33979

Authors: McGladdery, SH Pimstone, SN Clee, SM Bowden, JF Hayden, MR Frohlich, JJ
Citation: Sh. Mcgladdery et al., Common mutations in the lipoprotein lipase gene (LPL): effects on HDL-cholesterol levels in a Chinese Canadian population, ATHEROSCLER, 156(2), 2001, pp. 401-407

Authors: Clee, SM Loubser, O Collins, J Kastelein, JJP Hayden, MR
Citation: Sm. Clee et al., The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease, CLIN GENET, 60(4), 2001, pp. 293-300

Authors: Almqvist, EW Elterman, DS MacLeod, PM Hayden, MR
Citation: Ew. Almqvist et al., High incidence rate and absent family histories in one quarter of patientsnewly diagnosed with Huntington disease in British Columbia, CLIN GENET, 60(3), 2001, pp. 198-205

Authors: Otto, CJ Almqvist, E Hayden, MR Andrew, SE
Citation: Cj. Otto et al., The 'flap' endonuclease gene FEN1 is excluded as a candidate gene implicated in the CAG repeat expansion underlying Huntington disease, CLIN GENET, 59(2), 2001, pp. 122-127

Authors: Clee, SM Zwinderman, AH Engert, JC Zwarts, KY Molhuizen, HOF Roomp, K Jukema, JW van Wijland, M van Dam, M Hudson, TJ Brooks-Wilson, A Genest, J Kastelein, JJ Hayden, MR
Citation: Sm. Clee et al., Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease, CIRCULATION, 103(9), 2001, pp. 1198-1205

Authors: Backus, RC Ginzinger, DG Excoffon, KJDA Clee, SM Hayden, MR Eckel, RH Hickman, MA Rogers, QR
Citation: Rc. Backus et al., Maternal expression of functional lipoprotein lipase and effects on body fat mass and body condition scores of mature cats with lipoprotein lipase deficiency, AM J VET RE, 62(2), 2001, pp. 264-269

Authors: Leavitt, BR Guttman, JA Hodgson, JG Kimel, GH Singaraja, R Vogl, AW Hayden, MR
Citation: Br. Leavitt et al., Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin invivo, AM J HU GEN, 68(2), 2001, pp. 313-324

Authors: Falush, D Almqvist, EW Brinkmann, RR Iwasa, Y Hayden, MR
Citation: D. Falush et al., Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases, AM J HU GEN, 68(2), 2001, pp. 373-385

Authors: Lu, GQ Excoffon, KJDA Wilson, JE McManus, BM Rogers, QR Miao, L Kastelein, JJP Lewis, MES Hayden, MR
Citation: Gq. Lu et al., Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transfer, HUM GENE TH, 11(1), 2000, pp. 21-32

Authors: Metzler, M Helgason, CD Dragatsis, I Zhang, TQ Gan, L Pineault, N Zeitlin, SO Humphries, RK Hayden, MR
Citation: M. Metzler et al., Huntingtin is required for normal hematopoiesis, HUM MOL GEN, 9(3), 2000, pp. 387-394
Risultati: 1-25 | 26-50 | 51-69